STERIS plc (STE) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences.

Total Revenue Chart for STERIS plc

STERIS plc (STE) revenue for FY2026 was USD 5.9B, a 8.7% change from FY2025. STERIS plc's revenue grew from USD 8.8M in 1991 to USD 5.9B in 2026 (67353.4% over 35 years). Earnings per share grew from USD 0.15 in 2000 to USD 6.20 in 2025 (4036.1%). Revenue compound annual growth rate: 5-year CAGR of 13.8%, 10-year CAGR of 10.2%, 20-year CAGR of 8.5%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$22.59B
Implied Share Price
$231.78
Enterprise Value
$24.34B
Revenue (TTM)
$5.94B
EBITDA
$1.60B
Profit Margin
13.18%
Trailing P/E
29.19
Forward P/E
20.92
Price/Book (MRQ)
3.16
Price/Sales (TTM)
3.81
EV/EBITDA
15.27
EV/Revenue
4.10
Dividend Yield
1.06%
Book Value
$73.45
Free Cash Flow (FY2026)
$972.40M
Free Cash Flow Yield
4.30%

Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.